Safety of allogeneic hematopoietic stem cell transplantation in beta‐thalassemia patients with chronic hepatitis C infections treated at a pediatric center-Reference-Cited by-同舟云学术

Safety of allogeneic hematopoietic stem cell transplantation in beta‐thalassemia patients with chronic hepatitis C infections treated at a pediatric center

Published:2019-06-17 Issue:6 Volume:23 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Ramgopal Archana¹^ORCID,Lauko Adam¹,Rotz Seth¹^ORCID,Hanna Rabi¹

Affiliation:

1. Department of Hematology Oncology Cleveland Clinic Children’s Hospital Cleveland Ohio

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13520

Reference19 articles.

1. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

2. Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients

3. Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

4. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)

5. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report;Journal of Infection and Chemotherapy;2021-08

2. HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND SOLUTIONS;Mediterranean Journal of Hematology and Infectious Diseases;2020-04-27